Ligand Pharmaceuticals Incorporated (LGND) vs Rhythm Pharmaceuticals, Inc. (RYTM)

Ligand Pharmaceuticals Incorporated and Rhythm Pharmaceuticals, Inc. are both Biotechnology companies. Rhythm Pharmaceuticals, Inc. is the larger, with a market value of $6.8B against $6.1B — 1.1× the size. Rhythm Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Ligand Pharmaceuticals Incorporated trades at 30.1×. Ligand Pharmaceuticals Incorporated grew revenue faster over the last twelve months: 54.9% against 53.5%. Ligand Pharmaceuticals Incorporated has the higher net margin (67.9% vs −87.6%) and the higher return on invested capital (8.19% vs 0.00%). Across the 17 metrics below, Ligand Pharmaceuticals Incorporated leads on 16 and Rhythm Pharmaceuticals, Inc. on 1.